About this trial
It has been shown that reactions of human retinal photoreceptors to a light stimulus can be measured with custom-made, research prototype optical coherence tomography (OCT) systems. This can be used as a biomarker for the function of the photoreceptors. Due to the high technical demands on the system, however, the technique is currently not available for clinical purposes. In this pilot study a protocol to measure changes in retinal photoreceptor layer thickness before and after light stimulation shall be developed based on a commercial OCT system and newly developed algorithms. Other variables, such as circadian processes shall be investigated as well. After measurements in healthy volunteers, the protocol is planned to be applied in patients with primary open angle glaucoma (POAG) and age-related macular degeneration (AMD) to test for feasibility of the method in these patient groups.
Eligibility criteria
Qualifiers
men and women aged over 18 years
signed informed consent form
ametropia below 3 diopters
ability and willingness to follow instructions
Disqualifiers
Presence of any abnormalities preventing reliable measurements
Ocular inflammation and ocular disease interfering with the study aims
Use of photosensitizing medication (phototoxic drugs, photoallergic drugs) in the 3 months preceding the study
Presence of any condition with the possibility of causing photosensitivity, including systemic lupus erythematosus SLE, Porphyria, Vitiligo, Xeroderma Pigmentosum and Albinism
Trial design
Treatments tested in this trial
- White light stimulation